Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT
- PMID: 11170222
- DOI: 10.1002/1098-2396(200104)40:1<55::AID-SYN1026>3.0.CO;2-O
Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT
Abstract
MDMA-induced 5-HT neurotoxicity has been proposed to involve oxidative stress due to increased formation of hydroxyl radicals. Recently, MDMA-induced 5-HT neurotoxicity has been shown to be accompanied by a suppression of behavioral and neurochemical responses to a subsequent injection of MDMA. The intent of the present study was to examine whether suppression of the MDMA-induced formation of hydroxyl radicals by an antioxidant, ascorbic acid, attenuates both the MDMA-induced depletion of 5-HT and the functional consequences associated with this depletion. Treatment of rats with ascorbic acid suppressed the generation of hydroxyl radicals, as evidenced by the production of 2,3-dihydroxybenzoic acid from salicylic acid, in the striatum during the administration of a neurotoxic regimen of MDMA. Ascorbic acid also attenuated the MDMA-induced depletion of striatal 5-HT content. In rats treated with a neurotoxic regimen of MDMA, the ability of a subsequent injection of MDMA to increase the extracellular concentration of 5-HT in the striatum, elicit the 5-HT behavioral syndrome, and produce hyperthermia was markedly reduced compared to the responses in control rats. The concomitant administration of ascorbic acid with the neurotoxic regimen of MDMA prevented the diminished neurochemical and behavioral responses to a subsequent injection of MDMA. Finally, a neurotoxic regimen of MDMA produced significant reductions in the concentrations of vitamin E and ascorbic acid in the striatum and hippocampus. Thus, the MDMA-induced depletion of brain 5-HT and the functional consequences thereof appear to involve the induction of oxidative stress resulting from an increased generation of free radicals and diminished antioxidant capacity of the brain.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
-
Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT.J Psychopharmacol. 2010 Feb;24(2):267-74. doi: 10.1177/0269881109348163. Epub 2009 Dec 4. J Psychopharmacol. 2010. PMID: 19965941
-
Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT.Brain Res. 2005 Sep 21;1056(2):168-75. doi: 10.1016/j.brainres.2005.07.009. Brain Res. 2005. PMID: 16098955
-
The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.Neurotoxicol Teratol. 2004 Jul-Aug;26(4):571-7. doi: 10.1016/j.ntt.2004.03.008. Neurotoxicol Teratol. 2004. PMID: 15203179
-
Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.Neuropharmacology. 2008 Nov;55(6):1006-14. doi: 10.1016/j.neuropharm.2008.08.001. Epub 2008 Aug 12. Neuropharmacology. 2008. PMID: 18761360 Review.
-
3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.Psychopharmacology (Berl). 2007 Jan;189(4):407-24. doi: 10.1007/s00213-006-0322-6. Epub 2006 Mar 16. Psychopharmacology (Berl). 2007. PMID: 16541247 Free PMC article. Review.
Cited by
-
(±)3,4-methylenedioxymethamphetamine ("ecstasy") treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain.J Comp Neurol. 2012 Aug 1;520(11):2459-74. doi: 10.1002/cne.23048. J Comp Neurol. 2012. PMID: 22237931 Free PMC article.
-
Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA.Psychopharmacology (Berl). 2004 May;173(3-4):296-309. doi: 10.1007/s00213-004-1787-9. Epub 2004 Apr 9. Psychopharmacology (Berl). 2004. PMID: 15083265
-
Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine ("Ecstasy") induced cytoskeletal damage.J Neural Transm (Vienna). 2022 Jun;129(5-6):703-711. doi: 10.1007/s00702-022-02502-8. Epub 2022 Apr 14. J Neural Transm (Vienna). 2022. PMID: 35420371 Free PMC article.
-
Serotonin neurotoxins--past and present.Neurotox Res. 2004;6(7-8):589-614. doi: 10.1007/BF03033455. Neurotox Res. 2004. PMID: 15639791 Review.
-
Studies of oxidative stress mechanisms using a morphine / ascorbate animal model and novel N-stearoyl cerebroside and laurate sensors.J Neural Transm (Vienna). 2008;115(1):7-17. doi: 10.1007/s00702-007-0809-2. Epub 2007 Sep 25. J Neural Transm (Vienna). 2008. PMID: 17896074
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical